NCT03701828Completed
Liver Health and Metabolic Function in People With Obesity
Source: ClinicalTrials.gov · Last updated 19 Jun 2025
Brief summary (registry, in English)
This project aims to determine the effect of significant weight loss on rates on hepatic fibrogenesis in people with obesity.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 23 (actual)
- First submitted
- 10 Sept 2018
- Start date
- 1 Feb 2019
- Primary completion date
- 19 Feb 2024
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Obesity, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT03701828
What you commit to
- Study type: Interventional
- Participants enrolled: 23
- From 1 Feb 2019 to the primary completion date, 19 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous bariatric surgery
Other illness
- Significant organ disfunction/disease
- Liver disease other than NAFLD
Other
- Tobacco use
- Pregnancy
- Excessive alcohol use
Who the study is looking for
- Body mass index ≥35 kg/m2
- Scheduled for Bariatric surgery
Age in the registry: 21 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Washington University School of Medicine Coordinator of this site? Confirm its status | St Louis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.